Habara Toshiyuki, Sato Yasuharu, Takata Katsuyoshi, Iwaki Noriko, Okumura Hirokazu, Sonobe Hiroshi, Tanaka Takehiro, Orita Yorihisa, Abd Al-Kader Lamia, Asano Naoko, Ennishi Daisuke, Yoshino Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Shikaata-cho, Okayama, Japan.
J Clin Exp Hematop. 2012;52(2):91-9. doi: 10.3960/jslrt.52.91.
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma. Although many investigations have been performed on the prognostic factors of DLBCL, no reports have focused on localized nodal DLBCL. We examined the prognostic significance of 39 Japanese patients with localized nodal DLBCL with special reference to the germinal center B-cell-like (GCB) versus non-germinal center B-cell-like (NGCB) types. The median age was 65 years with 23 males and 16 females. Using Hans algorithm of immunohistochemistry, 18 patients (46%) exhibited GCB type and 21 (54%) exhibited NGCB type. Twenty-nine patients (74%) presented with disease in the neck (neck group) and 10 (26%) had disease in non-neck regions (non-neck group). Comparing Hans, Choi, and Muris algorithms, patients with GCB type showed statistically significant progression-free survival (PFS) only with Hans algorithm (P = 0.022, P = 0.100, and P = 0.130, respectively). Patient survival analyses revealed that GCB-type patients by Hans algorithm had a better PFS (P = 0.012), and neck-group patients had better PFS and overall survival (OS) (P = 0.018 and P = 0.012, respectively). Univariate analysis revealed that only neck vs. non-neck exhibited a significant difference in terms of OS (P = 0.026). Multivariate analysis revealed that GCB type by Hans algorithm and neck vs. non-neck were significantly different in terms of PFS (P = 0.025 and P = 0.033, respectively). Therefore, the subclassifications of GCB type vs. NGCB type and neck vs. non-neck are important predictive prognostic factors in localized nodal DLBCL.
弥漫性大B细胞淋巴瘤(DLBCL)是非霍奇金淋巴瘤最常见的形式。尽管针对DLBCL的预后因素已开展了许多研究,但尚无报告聚焦于局限性淋巴结DLBCL。我们研究了39例日本局限性淋巴结DLBCL患者的预后意义,特别参考了生发中心B细胞样(GCB)型与非生发中心B细胞样(NGCB)型。中位年龄为65岁,男性23例,女性16例。采用免疫组织化学汉斯算法,18例患者(46%)表现为GCB型,21例(54%)表现为NGCB型。29例患者(74%)疾病累及颈部(颈部组),10例(26%)疾病累及非颈部区域(非颈部组)。比较汉斯、崔氏和穆里斯算法,仅汉斯算法显示GCB型患者的无进展生存期(PFS)具有统计学显著差异(分别为P = 0.022、P = 0.100和P = 0.130)。患者生存分析显示,根据汉斯算法,GCB型患者的PFS更佳(P = 0.012),颈部组患者的PFS和总生存期(OS)更佳(分别为P = 0.018和P = 0.012)。单因素分析显示,仅颈部与非颈部在OS方面存在显著差异(P = 0.026)。多因素分析显示,根据汉斯算法的GCB型以及颈部与非颈部在PFS方面存在显著差异(分别为P = 0.025和P = 0.033)。因此,GCB型与NGCB型以及颈部与非颈部的亚分类是局限性淋巴结DLBCL重要的预测预后因素。